Free Trial

Alterity Therapeutics (ATHE) News Today

→ RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad)
Free ATHE Stock Alerts
$1.85
0.00 (0.00%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends
May 29, 2024 | globenewswire.com
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
May 8, 2024 | globenewswire.com
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
April 30, 2024 | globenewswire.com
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
April 29, 2024 | finance.yahoo.com
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
April 29, 2024 | globenewswire.com
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich's Ataxia
April 17, 2024 | finance.yahoo.com
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
April 10, 2024 | globenewswire.com
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
April 5, 2024 | finance.yahoo.com
Alterity Therapeutics Limited (ATHE)
March 26, 2024 | globenewswire.com
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
March 24, 2024 | morningstar.com
Alterity Therapeutics Ltd ADR ATHE
March 22, 2024 | seekingalpha.com
ATHE Alterity Therapeutics Limited
March 22, 2024 | wsj.com
Alterity Therapeutics Ltd. ADR
February 23, 2024 | msn.com
Alterity Therapeutics drops on capital raise
February 22, 2024 | benzinga.com
Alterity Therapeutics Stock (NASDAQ:ATHE), Short Interest Report
February 21, 2024 | marketbeat.com
Trading was temporarily halted for "ATHE" at 05:02 PM with a stated reason of "News pending."
February 20, 2024 | finance.yahoo.com
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
February 20, 2024 | globenewswire.com
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
January 29, 2024 | finance.yahoo.com
Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
January 22, 2024 | finance.yahoo.com
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
December 21, 2023 | finanznachrichten.de
ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
December 4, 2023 | finance.yahoo.com
Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
December 4, 2023 | marketwatch.com
Alterity Therapeutics Shares Up Fivefold on New Parkinson's Drug Data
December 4, 2023 | msn.com
Why Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today?
December 4, 2023 | finance.yahoo.com
Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data
December 4, 2023 | finance.yahoo.com
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
November 27, 2023 | finance.yahoo.com
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
November 22, 2023 | finance.yahoo.com
Alterity Therapeutics Limited's (ASX:ATH) CEO Compensation Is Looking A Bit Stretched At The Moment
November 22, 2023 | msn.com
Alterity Therapeutics, Edesa Biotech among healthcare movers
November 22, 2023 | marketwatch.com
Alterity Therapeutics ADRs Shares Dive 31% on Raised Capital
November 20, 2023 | marketbeat.com
Trading was temporarily halted for "ATHE" at 06:11 AM with a stated reason of "News pending."
November 16, 2023 | finanznachrichten.de
ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
November 16, 2023 | finance.yahoo.com
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
November 8, 2023 | finanznachrichten.de
ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
October 30, 2023 | finance.yahoo.com
Appendix 4C – Q1 FY24 Quarterly Cash Flow Report
August 31, 2023 | finance.yahoo.com
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
August 23, 2023 | finance.yahoo.com
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
August 22, 2023 | technews.tmcnet.com
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson's Disease and Movement Disorders
August 22, 2023 | finance.yahoo.com
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
August 15, 2023 | finance.yahoo.com
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
July 31, 2023 | finance.yahoo.com
Appendix 4C – Q4 FY23 Quarterly Cash Flow Report
July 26, 2023 | finance.yahoo.com
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
June 21, 2023 | finance.yahoo.com
Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023
May 30, 2023 | finance.yahoo.com
Alterity Therapeutics Initiates Second Phase 2 Study in Rare Parkinsonian Disorder
May 19, 2023 | finance.yahoo.com
Alterity Therapeutics CEO David Stamler to Present at the SHARE Series Monday Management Update on Monday, May 22, 2023
May 10, 2023 | finance.yahoo.com
Appendix 4C – Q3 FY23 Quarterly Cash Flow Report
May 10, 2023 | finance.yahoo.com
Alterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophy
April 26, 2023 | finance.yahoo.com
Alterity Therapeutics Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology
March 14, 2023 | msn.com
Alterity gets US patent, inks licensing pact to advance asset for Alzheimer's
March 14, 2023 | finance.yahoo.com
Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease
March 8, 2023 | finance.yahoo.com
Alterity Therapeutics Enrolls First Patient in Italy in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
Get Alterity Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATHE and its competitors with MarketBeat's FREE daily newsletter.

Hurry! Buy this stock before the Robinhood traders do! (Ad)

Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.

Click here to pay just $5 for a full year of Stealth Trades

ATHE Media Mentions By Week

ATHE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATHE
News Sentiment
▼
0.00

0.76
▲
Average
Medical
News Sentiment

ATHE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATHE Articles
This Week
▼
0

0
▲
ATHE Articles
Average Week

Get Alterity Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATHE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ATHE) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
Biden Nomination CANCELED?
And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...
The Freeport Society | Sponsored